Gene · 3078
Papers1,634
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
221 to 240 of 1,634
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Pericentromeric satellite lncRNAs are induced in cancer-associated fibroblasts and regulate their functions in lung tumorigenesis. | Cell Death Dis | 2023 | 36635266 | PubTator, text mining | PubMed |
| Exosomal proteomics identifies RAB13 as a potential regulator of metastasis for HCC. | Hepatol Commun | 2023 | 36633475 | PubTator, text mining | PubMed |
| Variants in complement genes are uncommon in patients with anti-factor H autoantibody-associated atypical hemolytic uremic syndrome. | Pediatr Nephrol | 2023 | 36622444 | PubTator, text mining | PubMed |
| Phytochemical Analysis and Antiproliferative Activity of Ulex gallii Planch. (Fabaceae), a Medicinal Plant from Galicia (Spain). | Molecules | 2023 | 36615543 | PubTator, text mining | PubMed |
| A proteomic profile of the healthy human placenta. | Clin Proteomics | 2023 | 36593452 | PubTator, text mining | PubMed |
| What lies in-between: C3 glomerulopathy with non-hemolytic renal microangiopathy and an ultra-rare C3 variant. | Am J Med Sci | 2023 | 36473547 | PubTator, text mining | PubMed |
| Mass Spectrometry-Based Proteomics Analysis of Human Substantia Nigra From Parkinson's Disease Patients Identifies Multiple Pathways Potentially Involved in the Disease. | Mol Cell Proteomics | 2023 | 36423813 | PubTator, text mining | PubMed |
| Assessing the Impact of Prophylactic Eculizumab on Renal Graft Survival in Atypical Hemolytic Uremic Syndrome. | Transplantation | 2023 | 36413152 | PubTator, text mining | PubMed |
| The Factor H protein family: The switchers of the complement alternative pathway. | Immunol Rev | 2023 | 36382387 | PubTator, text mining | PubMed |
| Kidney diseases. | Immunol Rev | 2023 | 36369988 | PubTator, text mining | PubMed |
| Alternative pathway diagnostics. | Immunol Rev | 2023 | 36305168 | PubTator, text mining | PubMed |
| Genetic variability shapes the alternative pathway complement activity and predisposition to complement-related diseases. | Immunol Rev | 2023 | 36089777 | PubTator, text mining | PubMed |
| Advanced Microfluidic Vascularized Tissues as Platform for the Study of Human Diseases and Drug Development. | Curr Neuropharmacol | 2023 | 35794768 | PubTator, text mining | PubMed |
| Concurrent acute kidney injury and pancreatitis in a female patient: Answers. | Pediatr Nephrol | 2023 | 35758996 | PubTator, text mining | PubMed |
| A Novel SPTA1 Mutation in a Patient with Hereditary Spherocytosis without a Family History and Coexisting Gilbert's Syndrome. | Intern Med | 2023 | 35650129 | PubTator, text mining | PubMed |
| Complement gene variant effect on relapse of complement-mediated thrombotic microangiopathy after eculizumab cessation. | Blood Adv | 2023 | 35533258 | PubTator, text mining | PubMed |
| Eculizumab for paediatric patients with atypical haemolytic uraemic syndrome: full dataset analysis of post-marketing surveillance in Japan. | Nephrol Dial Transplant | 2023 | 35438790 | PubTator, text mining | PubMed |
| Hemolytic-uremic syndrome: 24 years' experience of a pediatric nephrology unit. | J Bras Nefrol | 2023 | 35385571 | PubTator, text mining | PubMed |
| Recognition of Histone H3 Methylation States by the PHD1 Domain of Histone Demethylase KDM5A. | ACS Chem Biol | 2023 | 33621062 | PubTator, text mining | PubMed |
| Analysis of hemopexin plasma levels in patients with age-related macular degeneration. | Mol Vis | 2022 | 37089696 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/3078/papers?page=12